Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

6.180 +0.050 (+0.82%)
Official Closing Price Updated: 4:10 PM EST, Nov 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why Is Bausch Health (BHC) Up 17% Today? ↗
Today, investors in Bausch Health and BHC stock are cheering an announced $4 billion debt swap, which will push out the company's debt. 
Via InvestorPlace
News headline image
Snap, Meta Platforms, Pinterest And Some Other Big Stocks Moving Higher On Wednesday ↗
  Barnes & Noble Education, Inc. (NYSE: BNED) gained 16.8% to $2.64 after reporting upbeat quarterly sales. Bausch Health Companies Inc. (NYSE: BHC) gained 15.5% to $5.91. 
Via Benzinga
News headline image
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst ↗
 
Via Benzinga
News headline image
Expert Ratings for Bausch Health Companies ↗
Bausch Health Companies (NYSE:BHC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in... 
Via Benzinga
News headline image
Could This Company's HyBryte™ Provide A Safer, More Convenient Alternative To Cutaneous T-Cell Lymphoma Treatment? ↗
Patients always have hope if their cancers are detected early. Thanks to advanced research and therapies, the earlier the cancer is diagnosed and treated, the better the chance of it being cured. 
Via Benzinga
News headline image
Bausch Health Companies Inc. (NYSE:BHC) Shareholder Notice: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 08/12/2022 -- An investigation as announced over potential breaches of fiduciary duties by certain directors at Bausch Health Companies Inc. 
Via SBWire
News headline image
7 Stock Price Predictions That Are Actually Worth Listening To ↗
Investors may take advantage of analyst stock price predictions beyond the recent share price to discover promising investments. 
Via InvestorPlace
News headline image
Recap: Bausch Health Companies Q2 Earnings ↗
  Bausch Health Companies (NYSE:BHC) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Bausch Health Companies... 
Via Benzinga
News headline image
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday ↗
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... 
Via Benzinga
News headline image
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision ↗
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting. 
Via InvestorPlace
News headline image
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022 ↗
  
Via Benzinga
News headline image
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Benzinga Before The Bell: Apple's Strong China Revenue, Amazon's EV Partnership, Jack Ma To Cede Control Of Ant Financial And Other Top Financial Stories Friday, July 29 ↗
Reuters Tencent’s Overseas Ambitions Face Resistance From India 
Via Benzinga
News headline image
Bausch Health To Appeal Expected Court Decision On Xifaxan Patents ↗
Yesterday, Bausch Health Companies Inc (NYSE: BHC) stock closed 50% lower after the reports on the order on patent litigation over Xifaxan (rifaximin). 
Via Benzinga
News headline image
Nasdaq Rises 100 Points; US Economy Shrinks Again In Q2 ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. 
Via Benzinga
News headline image
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,... 
Via Benzinga
News headline image
Why Bausch Health's Market Cap Is Being Cut In Half Thursday: 'A Near Worst-Case Scenario' ↗
Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug. 
Via Benzinga
News headline image
Bausch Health (BHC) Stock Plunges 50% on Patent News ↗
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled. 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 108 companies set new 52-week lows. 
Via Benzinga
News headline image
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday ↗
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan. 
Via Benzinga
News headline image
Nasdaq Dips Over 100 Points; Meta Earnings Miss Estimates ↗
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday. 
Via Benzinga
News headline image
NIO Stock Falls as Grizzly Research Targets the EV Maker in New Short Report ↗
Shares of NIO stock are sinking lower today following the release of a Grizzly Research short report. Here's what you should know. 
Via InvestorPlace
News headline image
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... 
Via Benzinga
News headline image
Opening Day: Golden Sun Rises In Debut As Ivanhoe Electric Delays IPO ↗
Chinese tutorial services provider Golden Sun Education opened for trading this week, with its shares surging almost 300% following a $17.6 million initial public offering. Meanwhile, Ivanhoe Electric... 
Via Talk Markets
News headline image
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session ↗
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider. 
Via Benzinga
News headline image
Bausch Health to Postpone Its Planned Initial Public Offering (Ipo) of Its Solta Medical Skin-care Division Due to Market Instability.
The IPO process for Solta drew "substantial investor interest," according to a statement released by Bausch Health. "However, the business 
Via Best Stocks
Topics Initial Public Offering
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.